Press releases

Exclusive agreement with Berlin Chemie for Sitavig® in Eastern Europe and the CIS region

Navamedic ASA – Exclusive agreement with Vectans Pharma for the unique cold sore treatment product Sitavig®

Nomination of François Boutignon as Chief Innovation and Technology Officer

China approves commercialization for Oravig®

Exclusive licensing agreement with m8 Pharmaceuticals

Image Medias
230 Bureaux de la colline
92213 Saint-Cloud
France

contact@vectans.com

logo-vectans-bleu-04

Copyright © VECTANS PHARMA